Medical network - 26 September 22, fosun medicine, according to the announcement on the day of Shanghai fosun pharmaceutical (group) co., LTD, subsidiary hospital of Shanghai fosun investment (group) co., LTD., with 3 armour hospital in the third people's hospital of mianyang city signed the investment cooperation framework agreement to reach a framework agreement, fosun medicine to the hospital, in the form of cash investment, accounting for 80% of the shares; The third people's hospital of mianyang city has invested in the existing physical assets of the high and new branch, accounting for 20% of the joint venture.
This has been a year of investment cooperation with the second hospital. On January 11, fosun pharmaceuticals also wanted to control 60 per cent of huaian's second people's hospital in the same way.
▍ year-to-date, 13 a-share companies to invest more than 50 in the hospital
As of press time, according to statistics, 13 a-share companies have been involved in the merger or acquisition or establishment of 25 hospitals in 2017.
In terms of the acquisition targets, although mainly private hospitals, there are also public tertiary hospitals and secondary hospitals.
From the perspective of investors, there are both pharmaceutical companies and non-pharmaceutical companies, as well as medical institutions themselves, and pharmaceutical companies make up the majority of them. Among them, non-drug companies such as investment companies to invest in the sea, such as the medical service institutions such as innovative medical treatment.
In terms of the amount involved, the total investment is expected to be over 5 billion yuan.
At present, the two hospitals in addition to fosun pharmaceutical's proposed investment have not been publicly listed, and they have made A preliminary estimate of the investment amount of A share company, which is more than 3.2 billion yuan. But according to fosun medicine's share of the shares and hospitals that invest in two hospitals, it is estimated that the cash invested by fosun medicine is more than 1 billion yuan.
At the beginning of 2017, the relevant basic conditions of the a-share company in hospital are as follows:
(information information is compiled according to the information of the great tide, according to the release date from the near to far sorting, for reference)
▍ why more and more companies in medical service industry?
Policy support is essential
Policy encouragement is the direct catalyst. Since 2013, the capital investment medical institutions have become a breeze. More and more medical or related listed companies have joined the boom in investment hospitals since the two countries introduced supportive policies to encourage investment hospitals in the past two years.
Released in September 2013, the state council "about several opinions to promote the development of health services, by 2020, will cover basic to establish the whole life cycle of health service system, and assume the total scale of health services to achieve 8 trillion yuan of above.
On January 9, 2014 "about speed up the development of social do medical several opinions, clearly put forward:" give priority to support social capital held non-profit medical institutions, to speed up the formation of non-profit medical institutions as main body, for-profit medical institutions to complement of social medical system."
On June 15, 2015, promulgated by the state council "about promoting social do medical several policies and measures to speed up the development, put forward to accelerate social do medical institutions on the scale and level of development of various promotion measures.
2016 various relevant support policy more frequently, at the beginning of the year "2016 on promoting social do health to speed up the development of a number of policy measures to years in the planning and guiding principles of the establishment of medical institutions (2016 ~ 2020), as well as of December 5" issued by the general office of the state council on promoting social do medical several policies and measures to speed up the development of notice, all is over social do medical related encouragement policies and measures.
In 2017, we will vigorously implement the reform of mixed-ownership, encourage all kinds of capital to participate in the reform of mixed ownership of state-owned enterprises, and propose the promotion of government and social capital cooperation (PPP) mode. As a result, some companies with capital strength and good integration capabilities have been actively involved in public hospitals.
Drug regulatory policy, drug companies are under pressure to enter the hospital
In recent years, the reform of the pharmaceutical industry has entered the deep stage, and the drug regulatory policy has been continuously overweight. The profit space of drug production and operation enterprises is constantly being compressed, which is the "insurance control fee", "the proportion of medicine", "two-ticket" road policy to the sword and the pharmaceutical company.
In China such a predominantly generics, the innovation medicine relative lack of environment, compressive ability is being challenged, drug companies and listed companies as a public company needs to maintain sustained growth performance to investors. So companies need to find new sources of profit growth. Hospitals and medical services are the most relevant upstream and downstream relationships with pharmaceutical enterprises.
Therefore, in this juncture, the listed enterprises have established hospital merger and acquisition business, and a large number of investment institutions have begun to follow up, seeking for the appropriate medical institution acquisition targets in the market.
Even with the transformation of individual drug companies, medical service income has become the main source of enterprises. For example, hengkang medical treatment (previously only), daan gene, shinbang pharmaceutical and jinling pharmaceutical co., have more than 20% of the income of medical services, of which the proportion of hengkang medical services is more than 50%.
Corporate celebrity effect, cross - boundary investment medical care
Business leaders have poured into healthcare services such as jack ma, wang jianlin and xu jiayi.
Among the most notable is wang's wanda group, which has invested more than rmb144bn in healthcare.
On January 6, 2016, wanda group has with the British International hospital group (International HospitalsGroup Limited, referred to as IHG) signed a cooperation, wanda will be a total investment of 15 billion yuan, in Shanghai, chengdu, Qingdao construction three comprehensive International hospital, used by IHG operation management and IHG brand. This is the largest investment by a Chinese company in the healthcare industry. It is also seen as the beginning of wanda's push into healthcare.
In June, wang jianlin, chairman of wanda group, announced that he would invest $70 billion to build a medical industry park in chengdu and build a world-class medical center.
At the same time, wang jianlin signed a strategic cooperation agreement with huaxi dental hospital of sichuan university, and invested 9 billion yuan to build 300 huaxi dental chain clinics in wanda plaza.
In shortly before July 3, wanda group with three new signings in kunming in yunnan investment projects, including wanda planned investment of 50 billion yuan in the city of kunming, world-class medical care and health industrial park.
▍ investment after the health care industry regulatory problems
The listed company invests in the medical service field in the later management of the difficult problem. The ancient language cloud, the jiangshan mountain is difficult, guarding jiangshan is more difficult!
As more and more companies get involved in hospitals, it is becoming harder and harder to find quality targets. It is not easy to find the right investment mark, the investment will be managed well, and the profits return to the enterprise is the investment party diligently.
Shi lichen, a prominent medical industry expert, said that although many companies in China are making acquisitions in hospitals, most companies face the question of how to manage them after the acquisition. "How to build the hospital brand after the acquisition, how to operate within the hospital, and how the hospital's doctors' resources are configured will be a problem for the acquisition of the company."
In Shi Lichen view, many enterprises not to hospital after acquisition of hospital management, only perfect the industrial layout, and even some corporate takeovers hospital just because I saw other acquisitions to follow suit, thereby fail to realize that acquired hospital can achieve with their own resources other aggregation effect, promote the enterprise to the healthy development.
|
